Zdrowie i gospodarka · 19/11/2024
FDA Clears Path for Abbreviated New Drug Applications for HYDROCORTONE Injection
The FDA has determined that HYDROCORTONE (hydrocortisone sodium phosphate) injection, equivalent to 50 milligrams base/milliliter, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for this product.